Monthly Archives: April 2016

http://www.lslog.com/philips-looks-to-add-india-health-tech-venture-fund-to-existing-ones-in-israel-netherlands/Philips looks to add India health tech venture fund to existing ones in Israel, Netherlands

Philips looks to add India health tech venture fund to existing ones in Israel, Netherlands

Philips looks to add India health tech venture fund to existing ones in Israel, Netherlands Royal Philips is looking to invest globally in venture efforts to support healthcare technology startups. […]

http://www.lslog.com/dexcom-warns-on-malfunctioning-alarms-in-latest-cgm-german-agency-discloses/Dexcom warns on malfunctioning alarms in latest CGM, German agency discloses

Dexcom warns on malfunctioning alarms in latest CGM, German agency discloses

Dexcom warns on malfunctioning alarms in latest CGM, German agency discloses Continuous glucose monitor company Dexcom has hit a stumbling block. Some of its devices, including the G5 receiver for […]

http://www.lslog.com/pfizer-investors-stand-with-ceo-read-even-though-he-is-0-for-2-on-megamergers/Pfizer investors stand with CEO Read even though he is 0 for 2 on megamergers

Pfizer investors stand with CEO Read even though he is 0 for 2 on megamergers

Pfizer investors stand with CEO Read even though he is 0 for 2 on megamergers Pfizer CEO Ian Read walked away from its $160 billion merger with Allergan this week […]

http://www.lslog.com/buyers-eye-relypsa-and-its-hyperkalemia-drug/Buyers eye Relypsa and its hyperkalemia drug

Buyers eye Relypsa and its hyperkalemia drug

Buyers eye Relypsa and its hyperkalemia drug Redwood City, CA-based Relypsa has hired an investment bank to check out M&A offers, Reuters reported. Relypsa isn’t commenting but the news service […]

http://www.lslog.com/experts-worry-insulin-getting-too-expensive-for-many-in-u-s-and-worldwide/Experts worry insulin getting too expensive for many in U.S. and worldwide

Experts worry insulin getting too expensive for many in U.S. and worldwide

Experts worry insulin getting too expensive for many in U.S. and worldwide Healthcare professionals are concerned that hormone insulin meds, often the key diabetes treatment, are getting too costly for […]

http://www.lslog.com/study-minimally-invasive-bead-embolization-effective-at-inducing-weight-loss/Study: Minimally invasive bead embolization effective at inducing weight loss

Study: Minimally invasive bead embolization effective at inducing weight loss

Study: Minimally invasive bead embolization effective at inducing weight loss A small 7-patient trial has found that minimally invasive bariatric arterial embolization could be an effective approach to inducing hunger […]

http://www.lslog.com/medtronic-artificial-pancreas-may-hit-the-market-next-spring-as-pivotal-trial-nears-final-data/Medtronic artificial pancreas may hit the market next spring, as pivotal trial nears final data

Medtronic artificial pancreas may hit the market next spring, as pivotal trial nears final data

Medtronic artificial pancreas may hit the market next spring, as pivotal trial nears final data An artificial pancreas, a device that automatically regulates insulin dosage for Type 1 diabetes patients […]

http://www.lslog.com/allergan-takes-linzess-on-a-run-with-differentiation-push/Allergan takes Linzess on a run with differentiation push

Allergan takes Linzess on a run with differentiation push

Allergan takes Linzess on a run with differentiation push Every drugmaker wants to find differentiators for their products. And for Ironwood, it was obvious. “Is this a constipation drug that […]

http://www.lslog.com/illumina-expands-san-diego-hq-with-new-blackrock-owned-digs-starting-mid-2017/Illumina expands San Diego HQ with new Blackrock-owned digs starting mid-2017

Illumina expands San Diego HQ with new Blackrock-owned digs starting mid-2017

Illumina expands San Diego HQ with new Blackrock-owned digs starting mid-2017 The seemingly unstoppable Illumina is taking its march beyond its metaphorical one on Wall Street. It's signed a deal […]

http://www.lslog.com/pfizer-cancels-merger-with-allergan-hey-what-about-inflectra-biosimilar/Pfizer cancels merger with Allergan; hey, what about Inflectra biosimilar?

Pfizer cancels merger with Allergan; hey, what about Inflectra biosimilar?

It clearly depends on where you sit at to which news item is more significant: Pfizer’s proposed $160-billion merger with Allergan probably makes a lot of investment bankers and Wall […]